Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

SLXNSLXN
3 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in SILEXION THERAPEUTICS CORP

CITADEL ADVISORS LLC previously held 0 shares of SLXN (SILEXION THERAPEUTICS CORP), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$23,434

Total Shares Change

-12,205

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$2.55
0
2026-Q1
Increased
20,926
+71.5%
$26,7850.0%$1.66
20
2025-Q4
New
12,205
-
$23,4340.0%$1.73
29

Other major holders of SLXN: UBS Group AG, JONES FINANCIAL COMPANIES LLLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used